199 related articles for article (PubMed ID: 11062843)
1. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
[TBL] [Abstract][Full Text] [Related]
6. Physiological effects of botulinum toxin in spasticity.
Gracies JM
Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
8. Motor control testing of upper limb function after botulinum toxin injection: a case study.
Hurvitz EA; Conti GE; Flansburg EL; Brown SH
Arch Phys Med Rehabil; 2000 Oct; 81(10):1408-15. PubMed ID: 11030508
[TBL] [Abstract][Full Text] [Related]
9. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
Rousseaux M; Compère S; Launay MJ; Kozlowski O
J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
[TBL] [Abstract][Full Text] [Related]
11. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
13. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
15. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
[TBL] [Abstract][Full Text] [Related]
17. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
[TBL] [Abstract][Full Text] [Related]
19. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]